- Home
- TECX vs ZTR Comparison
TECX vs ZTR Comparison
Compare TECX & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- ZTR
- Stock Information
- Founded
- TECX 2019
- ZTR 1988
- Country
- TECX United States
- ZTR Australia
- Employees
- TECX N/A
- ZTR N/A
- Industry
- TECX
- ZTR Investment Managers
- Sector
- TECX
- ZTR Finance
- Exchange
- TECX Nasdaq
- ZTR Nasdaq
- Market Cap
- TECX 334.4M
- ZTR 338.8M
- IPO Year
- TECX 2018
- ZTR N/A
- Fundamental
- Price
- TECX $21.51
- ZTR $6.17
- Analyst Decision
- TECX Buy
- ZTR
- Analyst Count
- TECX 6
- ZTR 0
- Target Price
- TECX $79.20
- ZTR N/A
- AVG Volume (30 Days)
- TECX 172.8K
- ZTR 219.4K
- Earning Date
- TECX 05-08-2025
- ZTR 01-01-0001
- Dividend Yield
- TECX N/A
- ZTR 12.09%
- EPS Growth
- TECX N/A
- ZTR N/A
- EPS
- TECX N/A
- ZTR N/A
- Revenue
- TECX N/A
- ZTR N/A
- Revenue This Year
- TECX N/A
- ZTR N/A
- Revenue Next Year
- TECX N/A
- ZTR N/A
- P/E Ratio
- TECX N/A
- ZTR N/A
- Revenue Growth
- TECX N/A
- ZTR N/A
- 52 Week Low
- TECX $13.70
- ZTR $4.50
- 52 Week High
- TECX $61.07
- ZTR $6.60
- Technical
- Relative Strength Index (RSI)
- TECX 51.42
- ZTR 60.53
- Support Level
- TECX $21.20
- ZTR $6.06
- Resistance Level
- TECX $22.75
- ZTR $6.23
- Average True Range (ATR)
- TECX 1.43
- ZTR 0.09
- MACD
- TECX 0.01
- ZTR -0.00
- Stochastic Oscillator
- TECX 41.32
- ZTR 80.65
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.